Search Results

Displaying Results 701-725 of 2834 "'BC'"

Jun 04, 2026, 09:34 ET WISI Enables Greenlight to Modernize Video Delivery with ABR Receiver

VANCOUVER, BC, June 4, 2026 /PRNewswire/ -- WISI today announced the successful deployment of its ABR Receiver solution at Greenlight Community Broadband, enabling a more efficient and resilient approach to video delivery across

More news about: WISI


Jun 04, 2026, 08:41 ET LED Dental Launches VELscope Mantis: Next-Gen Oral Cancer Screening

documentation for everyday clinical use. Available June 30, 2026 through authorized distributors.VANCOUVER, BC, June 4, 2026 /PRNewswire/ -- LED Dental Inc. today announced that the VELscope Mantis, the latest generation

More news about: VELscope


Jun 04, 2026, 08:15 ET Clinicians to Share Practical Strategies for Point-of-Care Ultrasound Probe Disinfection at APIC26

and I think Tristel ULT really hits the mark."The APIC26 program also includes an educational session by Nancy Moureau, PhD, RN, CRNI, CPUI, VA-BC, CEO of PICC Excellence, on infection-prevention considerations for ultrasound-guided peripheral intravenous catheter insertion. Her session, "

More news about: Parker Laboratories


Jun 04, 2026, 07:30 ET /R E P E A T -- Keycafe Expands Executive Leadership with Appointments of Rudi Airisto and Robert Johnston as Company Enters Next Phase of Global Growth/

VANCOUVER, BC, June 3, 2026 /PRNewswire/ - Keycafe, a leader in cloud-based key management, today announced two senior additions to its executive team: Rudi Airisto as Vice President of Corporate Development, and Robert

More news about: KeyCafe Inc.


Jun 04, 2026, 07:00 ET Graphite One Welcomes Pentagon Report Endorsing Tax Credits and Allied IP Licensing to Build U.S. Battery Equipment Manufacturing Capacity

established non-core manufacturing technologies to rebuild domestic battery equipment manufacturing"VANCOUVER, BC , June 4, 2026 /PRNewswire/ - Graphite One Inc. (TSXV: GPH; OTCQX: GPHOF) ("Graphite One" or the "Company")

More news about: Graphite One Inc.


Jun 04, 2026, 00:30 ET Ballard Power announces results of 2026 Annual General Meeting of Shareholders

VANCOUVER, BC, June 4, 2026 /CNW/ - Ballard Power Systems (NASDAQ: BLDP) (TSX: BLDP) today announced results of its 2026 Annual General Meeting, which was held on June 3rd.

More news about: Ballard Power Systems Inc.


Jun 04, 2026, 00:30 ET Ballard Power announces results of 2026 Annual General Meeting of Shareholders

VANCOUVER, BC, June 4, 2026 /PRNewswire/ - Ballard Power Systems (NASDAQ: BLDP) (TSX: BLDP) today announced results of its 2026 Annual General Meeting, which was held on June 3rd.

More news about: Ballard Power Systems Inc.


Jun 03, 2026, 18:35 ET Keycafe Expands Executive Leadership with Appointments of Rudi Airisto and Robert Johnston as Company Enters Next Phase of Global Growth

VANCOUVER, BC, June 3, 2026 /PRNewswire/ - Keycafe, a leader in cloud-based key management, today announced two senior additions to its executive team: Rudi Airisto as Vice President of Corporate Development, and Robert

More news about: KeyCafe Inc.


Jun 03, 2026, 17:04 ET West Fraser Releases 2025 Sustainability Report

VANCOUVER, BC, June 3, 2026 /PRNewswire/ - Today, West Fraser Timber Co. Ltd. ("West Fraser" or the "Company") (TSX and NYSE: WFG) released its 2025 Sustainability Report. The report highlights the Company's sustainability

More news about: West Fraser Timber Co. Ltd.


Jun 03, 2026, 15:33 ET EUROPÄISCHE KOMMISSION ERTEILT ZULASSUNG FÜR IMDYLLTRA® VON AMGEN FÜR DIE BEHANDLUNG VON KLEINZELLIGEM LUNGENKREBS IM FORTGESCHRITTENEN STADIUM

Snook, 609-251-1407 (Medien)Casey Capparelli, 805-447-1746 (Investoren) REFERENZENMountzios G, Sun L, Cho BC, et al. Tarlatamab in small-cell lung cancer after platinum-based chemotherapy. N Engl J Med. 2025;393(4):349-361.Amgen. (2026) Imdylltra 1 mg

More news about: Amgen


Jun 03, 2026, 15:16 ET LA COMMISSION EUROPÉENNE APPROUVE IMDYLLTRA® D'AMGEN POUR LE TRAITEMENT DU CANCER DU POUMON À PETITES CELLULES DE STADE ÉTENDU

Snook, 609-251-1407 (médias)Casey Capparelli, 805-447-1746 (investisseurs) RÉFÉRENCESMountzios G, Sun L, Cho BC, et al. Tarlatamab in small-cell lung cancer after platinum-based chemotherapy. N Engl J Med. 2025;393(4):349-361.Amgen. (2026) Imdylltra 1 mg

More news about: Amgen


Jun 03, 2026, 14:25 ET EURÓPSKA KOMISIA SCHVÁLILA LIEK IMDYLLTRA® SPOLOČNOSTI AMGEN NA LIEČBU POKROČILÉHO ŠTÁDIA MALOBUNKOVÉHO KARCINÓMU PĽÚC

Snook, 609-251-1407 (médiá)Casey Capparelli, 805-447-1746 (investori) REFERENCIEMountzios G, Sun L, Cho BC, et al. Tarlatamab in small-cell lung cancer after platinum-based chemotherapy. N Engl J Med. 2025;393(4): 349 – 361.Amgen. (2026) Imdylltra

More news about: Amgen


Jun 03, 2026, 13:35 ET EVROPSKÁ KOMISE SCHVÁLILA PŘÍPRAVEK IMDYLLTRA® OD SPOLEČNOSTI AMGEN K LÉČBĚ EXTENZIVNÍHO STADIA MALOBUNĚČNÉHO KARCINOMU PLIC

(média)Casey Capparelli, 805-447-1746 (investoři) OdkazyMountzios G, Sun L, Cho BC, et al. Tarlatamab in small-cell lung cancer after platinum-based chemotherapy. N Engl J Med. 2025;393(4):349-361.Amgen. (2026)

More news about: Amgen


Jun 03, 2026, 11:51 ET What If the Best Way to Protect Data Was to Delete It First?

Issued on behalf of Integrated Quantum TechnologiesVANCOUVER, BC, June 3, 2026 /PRNewswire/ -- Equity-Insider.com

More news about: Equity Insider


Jun 03, 2026, 10:50 ET Rock Chips Just Hit 100 g/t Gold Next to a BHP-Drilled Copper System

Issued on behalf of Salazar Resources Limited (TSXV: SRL)VANCOUVER, BC, June 3, 2026 /PRNewswire/ -- USA News Group News Commentary

More news about: USA News Group


Jun 03, 2026, 10:47 ET The $1 Billion Bet to Take Fusion Public

Issued on behalf of General Fusion Inc.VANCOUVER, BC, June 3, 2026 /PRNewswire/ -- Equity-Insider.com News Commentary

More news about: Equity Insider


Jun 03, 2026, 10:21 ET KOMISJA EUROPEJSA ZATWIERDZA PREPARAT IMDYLLTRA® FIRMY AMGEN DO LECZENIA DROBNOKOMÓRKOWEGO RAKA PŁUCA W POSTACI ROZSIANEJ

(media)Casey Capparelli, 805-447-1746 (inwestorzy)DANE ŹRÓDŁOWEMountzios G, Sun L, Cho BC, et al. Tarlatamab in small-cell lung cancer after platinum-based chemotherapy (Tarlatamab w drobnokomórkowym raku płuca po chemioterapii opartej na związkach

More news about: Amgen


Jun 03, 2026, 09:43 ET ЕВРОПЕЙСКАЯ КОМИССИЯ ОДОБРИЛА ПРЕПАРАТ AMGEN IMDYLLTRA® ДЛЯ ЛЕЧЕНИЯ МЕЛКОКЛЕТОЧНОГО РАКА ЛЕГКОГО НА ЗАПУЩЕННОЙ СТАДИИ

(СМИ)Кейси Каппарелли (Casey Capparelli), 805-447-1746 (инвесторы) СПИСОК ЛИТЕРАТУРЫMountzios G, Sun L, Cho BC, et al. Tarlatamab in small-cell lung cancer after platinum-based chemotherapy. N Engl J Med. 2025;393(4):349-361.Amgen. (2026) Imdylltra 1 мг

More news about: Amgen


Jun 03, 2026, 09:27 ET LA CE APRUEBA IMDYLLTRA® DE AMGEN PARA EL CÁNCER DE PULMÓN DE CÉLULAS PEQUEÑAS EN ESTADIO AVANZADO

(medios)Casey Capparelli, 805-447-1746 (inversores) REFERENCIASMountzios G, Sun L, Cho BC, et al. Tarlatamab in small-cell lung cancer after platinum-based chemotherapy. N Engl J Med. 2025;393(4):349-361.Amgen.

More news about: Amgen


Jun 03, 2026, 09:00 ET Revelstoke Mountain Resort Expands Four-Season Offerings with New Homes, Cabot Golf and Resident Mountain Club

for four-season mountain living is becoming a reality in the heart of BC's Monashee MountainsREVELSTOKE, BC, June 3, 2026 /PRNewswire/ - Revelstoke Mountain Resort (RMR) has surpassed $50 million in real estate pre-sales

More news about: Revelstoke Mountain Resort


Jun 03, 2026, 06:45 ET Deployed but Not Optimized: TELUS Digital and Ryan Strategic Advisory Reveal the AI Performance Gap in Enterprise CX for 2026

agents assisted by AI, but most organizations lack the tools to assess and improve AI performance VANCOUVER, BC, June 3, 2026 /PRNewswire/ - New research commissioned by

More news about: TELUS Digital


Jun 03, 2026, 06:45 ET Deployed but Not Optimized: TELUS Digital and Ryan Strategic Advisory Reveal the AI Performance Gap in Enterprise CX for 2026

agents assisted by AI, but most organizations lack the tools to assess and improve AI performance VANCOUVER, BC, June 3, 2026 /CNW/ - New research commissioned by

More news about: TELUS Digital


Jun 03, 2026, 00:03 ET Johnson & Johnson presents new data further reinforcing the role of nipocalimab in lowering the autoantibodies driving Sjögren's disease

pathogenesis to targeted treatment. J Transl Autoimmun. 2025 Aug 26;11:100311. doi: 10.1016/j.jtauto.2025.100311.10 Carsons SE, Patel BC. Sjogren Syndrome. [Updated 2023 Jul 31]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from:

More news about: Johnson & Johnson


Jun 02, 2026, 20:24 ET Hydreight Announces Refiling of Interim Financial Statements

VANCOUVER, BC and LAS VEGAS, June 2, 2026 /PRNewswire/ - Hydreight Technologies Inc. ("Hydreight" or the "Company") (TSXV: NURS) (OTCQB: HYDTF) (FSE: SO6), a U.S.-focused digital health infrastructure platform, announces that

More news about: Hydreight Technologies Inc.


Jun 02, 2026, 18:50 ET JA Solar lidera el mercado de la energía fotovoltaica postciclo con avances en dos tecnologías y soluciones integradas

su vez, la plataforma BC de última generación de la empresa logró un importante hito con la celda HyperGen que mostró una eficiencia de conversión de energía del 28,2 %, un nuevo récord mundial certificado por TÜV Rheinland.La celda Hypergent se basa en la arquitectura BC avanzada, que integra

More news about: JA Solar Technology Co., Ltd.


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.